Home
Tools
TRIPS Flexibilities Database
Resources
Blog
About

Search

Medicines Law & Policy Research and resources on intellectual property and health

Home
Tools
TRIPS Flexibilities Database
Resources
Blog
About

Tag: WHA

Drug Price Transparency Calls Move from South Africa to World Health...

Medicines Law & Policy - May 18, 2019

Recent Posts

Uganda tells ARIPO: No more patents for pharmaceuticals
Corbyn’s Compulsory Licenses. Will they work?
Dutch Minister of Health writes open letter to pharma, threatens to name and shame
Cystic Fibrosis Buyers Club Shows the UK Government The Way

Posts by Subject

Access to Medicines ARIPO Cancer CDCA competition law Compulsory licensing compulsory licensing for export CRISPR cystic fibrosis Data exclusivity Delinkage dolutegravir European Union evergreening France Gilead Hepatitis C HIV IFPMA India innovation Italy LDCs market exclusivity Medicines Patent Pool Medicines Pricing Netherlands orkambi Orphan Drugs Patent Patents PrEP R&D Sofosbuvir SPC Supplementary Protection Certificates The Netherlands transparency TRIPS flexibilities Truvada UK United Nations High Level Panel WHO WIPO WTO

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: info@medicineslawandpolicy.net.

This work is licensed under Creative Commons.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok